A synthetic peptide for use as a blocking control in assays to test for specificity of Gabra5 antibody, Alternative Names: Gabra5 control peptide, Gabra5 antibody Blocking Peptide, Anti-Gabra5 Blocking Peptide, gamma-aminobutyric acid, GABA A receptor, subunit alpha 5 Blocking Peptide, A230018I05Rik Blocking Peptide, Gabra5, Gabra-5, Gabra 5, Gabra-5 Blocking Peptide, Gabra 5 Blocking Peptide
Optimal conditions should be determined by the investigator
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
Buffer
PBS
Handhabung
Avoid repeated freeze/thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20 °C long term.
Target
GABRA5
(gamma-aminobutyric Acid (GABA) A Receptor, alpha 5 (GABRA5))
Synonyme
GABRA5 Peptide, si:dkey-93p24.1 Peptide, A230018I05Rik Peptide, gamma-aminobutyric acid type A receptor alpha5 subunit Peptide, gamma-aminobutyric acid (GABA) A receptor, alpha 5 Peptide, gamma-aminobutyric acid type A receptor alpha 5 subunit Peptide, gamma-aminobutyric acid (GABA) A receptor, subunit alpha 5 Peptide, gamma-aminobutyric acid receptor subunit alpha-5 Peptide, GABRA5 Peptide, gabra5 Peptide, Gabra5 Peptide, LOC100653497 Peptide
Hintergrund
GABA, the major inhibitory neurotransmitter in the vertebrate brain, mediates neuronal inhibition by binding to the GABA/benzodiazepine receptor and opening an integral chloride channel.